权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Quality of Medication Treatment for Opioid Use Disorder in Medicaid-enrollees: The Effects of State Policies and Intiatives

医疗补助参与者阿片类药物使用障碍的药物治疗质量：国家政策和举措的影响

基本信息

批准号：
10392358
负责人：
BRADLEY D STEIN
金额：
$ 25.52万
依托单位：
RAND CORPORATION
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-07-01 至 2024-10-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10392358
关键词：
Address Affect Attention Buprenorphine Caring Characteristics Clinical Communities Counseling County Data Disadvantaged Drug usage Effectiveness Health Health Benefit Health Services Accessibility Individual Injectable Insurance Interview Laboratories Medicaid Medical Methadone Monitor Naltrexone National Institute of Drug Abuse Outcome Patients Performance Pharmaceutical Preparations Policies Population Pregnant Women Provider Public Health Quality of Care Research Resources Role Services Site Visit Structure Time Variant care costs comorbidity cost deviant dosage effective intervention ethnic minority federal policy health care disparity heroin use high risk population improved improved outcome informant opioid overdose opioid treatment program opioid use disorder parity prescription opioid misuse prior authorization racial and ethnic rural counties screening substance abuse treatment treatment duration waiver

项目摘要

Project Summary Opioid use disorders are a significant public health crisis, and medication treatment is the most effective intervention for individuals with opioid use disorder. State policies and initiatives have increased medication treatment utilization over the last decade, but increased utilization without attention to quality of care might limit the public health benefits of medication treatment. Many states have begun implementing policies and initiatives to improve quality, although with little empirical support of their effectiveness in real world settings. This project will characterize how quality care for Medicaid-enrollees receiving medication treatment for opioid use disorder and related health outcomes have changed over time, overall, and among historically underserved and high-risk populations. We will then examine the extent to which policies and initiatives that increase access and those aimed at improving quality are associated with better quality of care and related health outcomes, overall, and for historically underserved and high-risk populations

项目摘要阿片类药物使用障碍是一种重大的公共健康危机，药物治疗是最有效的对阿片类药物使用障碍患者的干预。国家政策和举措增加了用药过去十年的治疗利用率，但未注意护理质量的利用率增加可能会限制药物治疗对公众健康的好处。许多州已经开始实施政策和提高质量的举措，尽管其在现实世界环境中的有效性鲜有经验支持。该项目将描述如何为接受阿片类药物治疗的医疗补助参与者提供高质量的护理使用障碍和相关的健康结果随着时间的推移而变化，总体上和历史上服务不足和高危人群。然后，我们将研究政策和倡议在多大程度上增加机会和旨在提高质量的机会与更好的护理质量和相关总体健康结果，以及历史上服务不足和高危人群的健康结果

项目成果

期刊论文数量（36）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Use of buprenorphine for those with employer-sponsored insurance during the initial phase of the COVID-19 pandemic.

DOI：
10.1016/j.jsat.2021.108384
发表时间：
2021-10
期刊：
Journal of substance abuse treatment
影响因子：
3.9
作者：
Cantor J;Dick AW;Haffajee R;Pera MF;Bravata DM;Stein BD;Whaley CM
通讯作者：
Whaley CM

State Policies and Buprenorphine Prescribing by Nurse Practitioners and Physician Assistants.

护士从业者和医师助理的国家政策和丁丙诺啡处方。

DOI：
10.1177/10775587221086489
发表时间：
2022-12
期刊：
Medical care research and review : MCRR
影响因子：
0
作者：
Harrison JM;Kerber R;Andraka-Christou B;Sorbero M;Stein BD
通讯作者：
Stein BD

Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019.

DOI：
10.1080/07853890.2023.2171107
发表时间：
2023-12
期刊：
Annals of medicine
影响因子：
4.4
作者：
通讯作者：

Common themes in early state policy responses to substance use disorder treatment during COVID-19.

DOI：
10.1080/00952990.2021.1903023
发表时间：
2021-07-04
期刊：
The American journal of drug and alcohol abuse
影响因子：
0
作者：
Andraka-Christou B;Bouskill K;Haffajee RL;Randall-Kosich O;Golan M;Totaram R;Gordon AJ;Stein BD
通讯作者：
Stein BD

Buprenorphine prescriber monthly patient caseloads: An examination of 6-year trajectories.